Quintiles ranks first in Pan-European clinical investigator study

Quintiles Transnational Corp. has announced that an independently conducted study of clinical investigator sites across Europe placed Quintiles first in overall satisfaction.

Quintiles was also rated first in several other indicators of a clinical investigator’s commitment to work with the world’s leading pharmaceutical services provider.

Some 84% of sites indicated that they were satisfied or extremely satisfied with their relationship with Quintiles.

The study, blinded and conducted by a third party, asked more than 300 European clinical investigators in 18 countries to rate their relationships and experience with Clinical Research Organizations (CROs).

Investigators recruit patients and collect data for CROs and their pharmaceutical and biotechnology sponsors in studies that test drugs for safety and efficacy.

Quintiles and eight other CROs were rated on 15 attributes by the investigator sites, including overall satisfaction, relationship building and allocation of resources for projects, including staff time.

Clinical sites were asked to assign a percentage of resources – such as time spent on patient recruitment – that they had used on clinical studies with each CRO.

Quintiles was allocated 38% of resources by the sites, with the nearest competitor being assigned only 13%, according to the survey.

As for expected allocation of resources in the future, sites plan to continue giving additional resources to Quintiles projects at about a 3:1 ratio over other CROs.